Unavailable

11th Biosimilars and Follow-on Biologics 2018 Americas

Event Information

Share this event

Date and Time

Location

Location

District of Columbia

Washington, District of Columbia

View Map

Friends Who Are Going
Event description

Description

Paradigm Global Events is once again hosting 'Biosimilars & Follow-on Biologics 2018 Americas'.
It will cover a diverse range of topic and address the challenges and obstacle encountered by the industry from development to successful market of biosimilars. It will also offer and provide a unique platform for knowledge sharing and convergence from Pharmaceuticals, Biotechnology, Regulatory and many more.

Please go to our website to find out more information and Register for an early bird discount

http://www.paradigmglobalevents.com/

We look forward to seeing you at the Congress!
Sincerely,
PGE



The increasing pressure to decrease healthcare expenditures, growing demand due to its cost-effectiveness, expanding occurrence of different diseases, increasing numbers of biologics losing their market exclusivity, positive outcomes in ongoing clinical trials and rising demand in various therapeutic applications are all contributing factors for growth of the biosimilars market. Between 2015 and the end of 2019, 39 biologics with combined US sales of $41 billion, representing 30% of the total market will lose their marketing exclusivity. This resulted in huge interest by big pharma and biotech company venturing into the Biosimilar sector in order to gain a slice of multibillion worth of biologics market. Other factors increasing the demand for biosimilar drugs include rising disease incidences across the globe and better access to healthcare for all nations.

Circumstance such as high manufacturing complexities and costs, rigorous regulatory requirements in countries, and innovative strategies by biologic drug manufacturers to restrict the entry of new players are restraining the growth of this market.

In this congress, we will cover a diverse range of topic and address the challenges and obstacle encountered by the industry from development to successful market of biosimilars.

This will also offer and provide a unique platform for knowledge sharing and convergence from Pharmaceuticals, Biotechnology, Regulatory and many more.

Share with friends

Date and Time

Location

District of Columbia

Washington, District of Columbia

View Map

Save This Event

Event Saved